74 related articles for article (PubMed ID: 21141955)
1. Study of various presentation forms for a peptide mimetic of Neisseria meningitidis serogroup B capsular polysaccharide.
Garay H; Menéndez T; Cruz-Leal Y; Coizeau E; Noda J; Morera V; Guillén G; Albericio F; Reyes O
Bioconjug Chem; 2011 Jan; 22(1):33-41. PubMed ID: 21141955
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
Menéndez T; Santiago-Vispo NF; Cruz-Leal Y; Coizeau E; Garay H; Reyes O; Batista Y; Cobas K; Carmenate T; Chinea G; Guillén G
Int J Med Microbiol; 2011 Jan; 301(1):16-25. PubMed ID: 20708963
[TBL] [Abstract][Full Text] [Related]
3. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
Prinz DM; Smithson SL; Westerink MA
J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate.
Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R
Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338
[TBL] [Abstract][Full Text] [Related]
5. A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide.
Amir-Kroll H; Riveron L; Sarmiento ME; Sierra G; Acosta A; Cohen IR
Vaccine; 2006 Oct; 24(42-43):6555-63. PubMed ID: 16843573
[TBL] [Abstract][Full Text] [Related]
6. Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci.
Beninati C; Midiri A; Mancuso G; Biondo C; Arigò M; Gerace E; Papasergi S; Gambuzza M; Boretti M; Magliani W; Conti S; Polonelli L; Teti G
J Exp Med; 2006 Jan; 203(1):111-8. PubMed ID: 16390937
[TBL] [Abstract][Full Text] [Related]
7. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
8. The immunogenicity of a conformationally restricted peptide mimetic of meningococcal lipooligosaccharide.
Tiwana H; Clow KJ; Hall C; Feavers IM; Charalambous BM
Scand J Immunol; 2005 Oct; 62(4):385-92. PubMed ID: 16253126
[TBL] [Abstract][Full Text] [Related]
9. Comparison of long-term humoral memory development after immunisation against Neisseria meningitidis B or diphtheria toxoid.
Cruz SC; Silva GP; Sampaio FJ; Souza SL; Dias AA; Milagres LG
Vaccine; 2010 Oct; 28(42):6841-6. PubMed ID: 20719254
[TBL] [Abstract][Full Text] [Related]
10. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.
Zhu D; Barniak V; Zhang Y; Green B; Zlotnick G
Vaccine; 2006 Jun; 24(26):5420-5. PubMed ID: 16621173
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.
Park IH; Youn JH; Choi IH; Nahm MH; Kim SJ; Shin JS
Infect Immun; 2005 Oct; 73(10):6399-406. PubMed ID: 16177311
[TBL] [Abstract][Full Text] [Related]
12. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
[TBL] [Abstract][Full Text] [Related]
13. Peptides that mimic the group B streptococcal type III capsular polysaccharide antigen.
Pincus SH; Smith MJ; Jennings HJ; Burritt JB; Glee PM
J Immunol; 1998 Jan; 160(1):293-8. PubMed ID: 9551983
[TBL] [Abstract][Full Text] [Related]
14. The serogroup A capsular polysaccharide from Neisseria meningitidis enhances the cell-mediated immunity and the protective capacity induced by a dengue fusion protein in mice.
Hermida L; Valdés I; Gil L; Bernardo L; Lazo L; Romero Y; Guzmán MG; Guillén G
Arch Virol; 2012 May; 157(5):987-91. PubMed ID: 22350649
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design.
Oomen CJ; Hoogerhout P; Kuipers B; Vidarsson G; van Alphen L; Gros P
J Mol Biol; 2005 Sep; 351(5):1070-80. PubMed ID: 16038932
[TBL] [Abstract][Full Text] [Related]
16. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
Franke ED; Corradin G; Hoffman SL
J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
[TBL] [Abstract][Full Text] [Related]
17. Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine.
Jennings HJ; Roy R; Gamian A
J Immunol; 1986 Sep; 137(5):1708-13. PubMed ID: 3091688
[TBL] [Abstract][Full Text] [Related]
18. Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier.
Guirola M; Urquiza D; Alvarez A; Cannan-Haden L; Caballero E; Guillén G
FEMS Immunol Med Microbiol; 2006 Mar; 46(2):169-79. PubMed ID: 16487298
[TBL] [Abstract][Full Text] [Related]
19. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
[TBL] [Abstract][Full Text] [Related]
20. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
